EwingCole, one of the nation's leading architecture, engineering, and interior design firms, is pleased to announce that opening ceremonies for the six-story expansion of United Therapeutics' downtown campus took place on Friday, September 21st. The 210,000 square-foot, elliptical shaped "Unisphere," is the largest site Net Zero commercial building in the US and houses clinical operations for pulmonary disease, heart failure, and organ transplantation as well as In Silico molecular biology – a virtual drug development lab.
"This smart building takes advantage of multiple sustainability strategies," said Jared Loos, PE, AIA, EwingCole CEO. "It has no operational carbon footprint because the electrical and thermal energy it uses is renewably generated on site. It is truly an engineering marvel."
Strategies employed to achieve Net Zero status include the following:
"The result is something pretty amazing," said Loos. "This is truly a one of a kind building that sets the bar for other owners, designers, developers, and builders."
The building team includes architect & engineer - EwingCole; contractor – Whiting-Turner; owners' representatives - Stranix Associates.
Led by chairman and CEO Dr. Martine Rothblatt, United Therapeutics is a biotechnology company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening conditions. One of Greater Washington's largest bioscience firms, United Therapeutics now occupies 435,000 square feet of office and lab space in Silver Spring.
EwingCole | http://www.ewingcole.com